Showing 14,441 - 14,460 results of 99,680 for search '(( 50 ((nn decrease) OR (teer decrease)) ) OR ( 5 ((step decrease) OR (a decrease)) ))', query time: 1.22s Refine Results
  1. 14441
  2. 14442
  3. 14443
  4. 14444
  5. 14445

    Down-Regulation of Annexin A Proteins in Human Mesangial Cells by TEGDMA and Bis-GMA Treatment Disrupts Proteins Involved in Cellular Function by Ayse Nur Dogan (21015836)

    Published 2025
    “…Western blotting and densitometric analysis further demonstrated downregulation of annexin A proteins, including annexin A2 and annexin A5, in human mesangial cells treated with TEGDMA. …”
  6. 14446

    table3_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  7. 14447

    table1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  8. 14448

    image2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  9. 14449

    table2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  10. 14450

    image1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  11. 14451

    table4_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  12. 14452

    Data_Sheet_1_Association between plasma vitamin B5 and coronary heart disease: Results from a case-control study.docx by Pengfei Sun (773177)

    Published 2022
    “…In the threshold effect analysis, the risk of CHD significantly decreased as the vitamin B5 concentration increased (per 10 ng/ml increment: OR, 0.71; 95% CI, 0.57–0.89) in participants with a plasma vitamin B5 concentration of <40.95 ng/ml; however, an increased plasma vitamin B5 concentration was no longer associated with a decreased risk of CHD (per 10 ng/ml increment: OR, 1.00; 95% CI, 0.87–1.14) in participants with a plasma vitamin B5 concentration of ≥40.95 ng/ml. …”
  13. 14453
  14. 14454
  15. 14455

    Effects of ablation of I1 neurons on modulation of the pumping rate by green light illumination at low intensity (A) The frequency of pumping before, during, and after light illumi... by Megumi Takahashi (4720299)

    Published 2017
    “…WT (N2): n = 3 worms, 17 trials; <i>unc-7</i>: n = 3 worms, 14 trials; <i>unc-31</i>: n = 3 worms, 15 trials; <i>unc-31;unc-7</i>: n = 3 worms, 15 trials; WT (N2), I1 ablation: n = 4 worms, 19 trials; <i>unc-31</i>, I1 ablation: n = 5 worms, 23 trials. (B) Relative pumping rate during the 10 s period after illumination was started as calculated from the data shown in (A). …”
  16. 14456
  17. 14457
  18. 14458
  19. 14459
  20. 14460

    Carbon Monoxide Releasing Molecule-A1 (CORM-A1) Improves Neurogenesis: Increase of Neuronal Differentiation Yield by Preventing Cell Death by Ana S. Almeida (220024)

    Published 2016
    “…Still, CORM-A1 increased cell proliferation assessed by ki67 expression and also prevented cell death, which was followed by increased Bcl-2 expression, decreased levels of active caspase-3 and PI uptake. …”